Pierre Loap
Impact in
- Radiation top 5%
- Advanced Radiotherapy Techniques
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 27
- Oncology 25
- HER2/EGFR in Cancer Research 7
- PARP inhibition in cancer therapy 6
- Co-authors
- Youlia Kirova (76 shared papers)Alain Fourquet (37 shared papers)K. Kirov (5 shared papers)Ludovic De Marzi (17 shared papers)Delphine Loirat (13 shared papers)Ester Orlandi (13 shared papers)Youlia Kirova (18 shared papers)R. Dendale (12 shared papers)
- Journals
- Cancers (11 papers)International Journal of Radiation Oncology*Biology*Physics (9 papers)Strahlentherapie und Onkologie (7 papers)Acta Oncologica (5 papers)Radiotherapy and Oncology (4 papers)
- Partner nations
- FranceItalyUnited States
In The Last Decade
Pierre Loap
79 papers receiving 873 citations
Peers
Comparison fields: 5 of 59
- Radiation 165
- Cancer Research 155
- Oncology 229
- Pulmonary and Respiratory Medicine 232
- Cardiology and Cardiovascular Medicine 150
Countries citing papers authored by Pierre Loap
This map shows the geographic impact of Pierre Loap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Loap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Loap more than expected).
Fields of papers citing papers by Pierre Loap
This network shows the impact of papers produced by Pierre Loap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Loap. The network helps show where Pierre Loap may publish in the future.
Co-authors
The 25 scholars most cited alongside Pierre Loap, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 67 | |
| 2 | 2022 | 52 | |
| 3 | 2021 | 49 | |
| 4 | 2020 | 42 | |
| 5 | 2020 | 39 | |
| 6 | 2021 | 36 | |
| 7 | 2021 | 34 | |
| 8 | 2022 | 29 | |
| 9 | 2021 | 27 | |
| 10 | 2020 | 27 | |
| 11 | 2021 | 25 | |
| 12 | 2020 | 25 | |
| 13 | 2020 | 24 | |
| 14 | 2023 | 22 | |
| 15 | 2023 | 21 | |
| 16 | 2022 | 21 | |
| 17 | 2020 | 20 | |
| 18 | 2020 | 19 | |
| 19 | 2021 | 17 | |
| 20 | 2021 | 16 |
About Pierre Loap
Pierre Loap is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiation and Pathology and Forensic Medicine, having authored 103 papers that have together received 880 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (27 papers), Advanced Radiotherapy Techniques (13 papers), Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Radiation Therapy and Dosimetry (8 papers), Lymphoma Diagnosis and Treatment (8 papers), HER2/EGFR in Cancer Research (7 papers), PARP inhibition in cancer therapy (6 papers) and Breast Lesions and Carcinomas (5 papers). The work is most often cited by research in Radiation (165 citations), Cancer Research (155 citations), Oncology (229 citations), Pulmonary and Respiratory Medicine (232 citations) and Cardiology and Cardiovascular Medicine (150 citations). Pierre Loap has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Youlia Kirova, Alain Fourquet, K. Kirov, Ludovic De Marzi, Delphine Loirat, Ester Orlandi, Youlia Kirova, R. Dendale, Vincent Servois and Amelia Barcellini. Their work appears in journals such as Cancers, International Journal of Radiation Oncology*Biology*Physics, Strahlentherapie und Onkologie, Acta Oncologica and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.